GeneDx Holdings Corp.

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

WGSNasdaqHealthcareDiagnostics & Research
$51.99 +1.84 (+3.67%)

Company Overview

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Price Chart

Historical Trend (Absolute Values)
WGS Price
05/1305/2105/29

Financial Metrics

Market Capitalization$1.55B
P/E Ratio
Earnings Per Share (EPS)-$3
Dividend Yield
Beta (Volatility)2.072
Price to Book (P/B)4.9336
52-Week Range$32.21 - $170.87

LAST SCRARED: May 30, 2026

Compare WGS

Analyze valuation multiples and growth parameters side-by-side with other public equities.

Compare Stock Now
VersusHub

© 2026 VersusHub. All rights reserved.